189330 — XIIlab Co Income Statement
0.000.00%
Last trade - 00:00- KR₩45bn
- KR₩40bn
- KR₩9bn
Annual income statement for XIIlab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11,162 | 5,778 | 9,897 | 3,663 | 9,093 |
| Cost of Revenue | |||||
| Gross Profit | 2,584 | 1,376 | 473 | 188 | 1,310 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10,455 | 7,771 | 14,823 | 10,574 | 14,378 |
| Operating Profit | 707 | -1,994 | -4,926 | -6,911 | -5,285 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 522 | -1,875 | -4,545 | -6,459 | -5,186 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 700 | -2,136 | -4,545 | -6,459 | -5,187 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 700 | -2,136 | -4,545 | -6,459 | -5,187 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 700 | -2,136 | -4,545 | -6,459 | -5,187 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 131 | -320 | -653 | -921 | -738 |
| Dividends per Share |